Global Intraocular Lens Market - By Type: Monofocal IOLs, Multifocal IOLs, Toric IOLs, Extended Depth-of-Focus (EDOF) IOLs; By Material: Hydrophobic Acrylic, Hydrophilic Acrylic, Silicone, PMMA (Polymethylmethacrylate), By End User: Hospitals, Ophthalmic Clinics, Ambulatory Surgical Centers (ASCs), By Region: North America, Europe, Asia-Pacific, Latin America, Middle East & Africa.
1 | Market Overview
The global intraocular lens (IOL) market is experiencing strong growth, driven by the rising incidence of cataracts, an increasing aging population, and heightened demand for refractive error correction. IOLs are artificial lenses implanted during cataract or refractive lens exchange (RLE) surgeries to restore vision. They come in various types, including monofocal, multifocal, toric, and extended depth-of-focus (EDOF) lenses, offering customized vision correction across multiple focal points.
As patient expectations rise and surgical techniques advance, the demand for premium IOLs and custom lens technologies is surging. Furthermore, emerging economies are expanding coverage for cataract surgery, while high-income markets are experiencing rapid adoption of lifestyle-enhancing IOLs.
2 | Market Size and Forecast
|
Year |
Market Value (USD Billion) |
Notes |
|
2019 |
3.6 |
Historical benchmark |
|
2024 |
5.2 |
Five-year CAGR 7.7% |
|
2031 |
9.3 |
Seven-year CAGR 8.3% |
The market is projected to nearly double by 2031, driven by favorable reimbursement, innovation in lens materials, and strong volume growth in Asia-Pacific and Latin America.
3 | Key Market Drivers
4 | Market Challenges
5 | Competitive Landscape
The IOL market is consolidated among global ophthalmic device manufacturers offering broad lens portfolios and surgical support platforms.
Market Share Estimates (2024):
|
Company |
Estimated Market Share |
Key Products |
|
Alcon |
38% |
AcrySof® IQ, PanOptix® trifocal, Vivity™ EDOF IOLs |
|
Johnson & Johnson Vision |
25% |
TECNIS® Synergy™, Eyhance®, Symfony® IOLs |
|
Bausch + Lomb |
14% |
enVista®, Crystalens®, Akreos® lenses |
|
Carl Zeiss Meditec |
10% |
CT LUCIA™, AT LISA®, trifocal and toric IOLs |
|
Others (Rayner, HOYA, SIFI) |
13% |
Niche and regional offerings |
6 | Market Segmentation
By Type:
By Material:
By End User:
By Region:
7 | Strategic Outlook
Future growth in the IOL market will be driven by next-generation light-adjustable lenses, AI-assisted biometric calculations, and remote postoperative monitoring. Companies that integrate patient education with customized surgical packages and surgeon-focused delivery models will capture long-term market share.
Need help?
Chat with our team in a minute.